United States Hematology Testing Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast 2027

Report Description

United States hematology testing market is expected to witness significant CAGR during the forecast period. Key factors propelling the growth of this market include growing prevalence and awareness about blood disorders such as thalassemia, coupled with increasing healthcare expenditure. Moreover, extensive R&D activities and effort by manufacturers to develop cost-effective and advanced hematology systems is acting as major growth drivers for United States hematology testing market. Also, companies are coming up with point-of-care devices due to shifting trend towards patient-self-testing, which is further expected to drive the market growth in coming years.

Additionally, rising patient population and technological advancement in healthcare sector is creating profitable opportunities for United States hematology testing market. Hematological test is helpful in diagnosing anemia, hemophilia, blood-clotting disorders, infections and leukemia. The test includes calculation of WBC, RBC, and platelets. With introduction of more efficient and advanced hematology analyzers, the market is expected to grow significantly through 2027.

United States hematology testing market can be categorized based on product type, type of test, reagents, application, end user and region. Based on end user, the market can be segmented into diagnostic laboratories, hospitals, clinical testing laboratories, academic institutes, patient self-testing, others. Among them, diagnostic laboratories segment held largest market share in 2021 and is further expected to grow significantly during the forecast period owing to increasing number of diagnostic laboratories and availability of advanced instruments.

Major players operating in the United States hematology testing market include Abbott Laboratories, Inc. , Siemens Healthcare Diagnostics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Inc., Novo Nordisk, Inc., Fluidigm Corporation and Microfluidics International Corporation, among others. The market players are involved in new product launches, mergers & acquisitions and collaborations in order to strengthen their position in United States hematology testing market.

Objective of the Study:

To analyze and estimate the market size of United States hematology testing market from 2017 to 2020.
To estimate and forecast the market size of United States hematology testing market from 2021 to 2027 and growth rate until 2027.
To classify and forecast United States hematology testing market based on product type, type of test, reagents, application, end user, company and regional distribution.
To identify dominant region or segment in the United States hematology testing market.
To identify drivers and challenges for United States hematology testing market.
To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States hematology testing market.
To conduct pricing analysis for United States hematology testing market.
To identify and analyze the profile of leading players operating in United States hematology testing market.
To identify key sustainable strategies adopted by market players in United States hematology testing market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hematology testing system manufacturers across United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across United States.

TechSci Research calculated the market size of United States hematology testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Hematology testing system manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to hematology testing
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hematology testing system manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute	Details
Base Year	2021
Historical Years	2017 – 2020
Estimated Year	2022E
Forecast Period	2023F – 2027F
Quantitative Units	Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	Product Type Type of Test Reagents Application End User
Region Scope	South-Region, West-Region, Mid-West Region & Northeast-Region
Key Companies Profiled	Abbott Laboratories, Inc. , Siemens Healthcare Diagnostics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Inc., Novo Nordisk, Inc., Fluidigm Corporation and Microfluidics International Corporation
Customization Scope	10% free report customization with purchase. Addition or alteration to regional & segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, United States hematology testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

United States Hematology Testing Market, By Product Type:

Hematology Instruments

Hematology Analyzers
Flow Cytometers
Coagulation Analyzers
Others

Hematology Consumables

Reagents
Stains
Controls & Calibrators
Others

United States Hematology Testing Market, By Type of Test:

Complete Blood Count Analysis
White Blood Cell Analysis
Hemoglobin
Platelet Function
Reticulocytes
Others

United States Hematology Testing Market, By Reagents:

Coagulation Reagents
Flow Cytometry Reagents
Immuno-Hematology Reagents
Others

United States Hematology Testing Market, By Application:

Anemia
Hemoglobinopathy
leukemia/lymphoma Phenotyping
Hematology Pathophysiology
Complete Blood Count

United States Hematology Testing Market, By End User:

Diagnostic Laboratories
Hospitals
Clinical Testing Laboratories
Academic Institutes
Patient Self-testing
Others

United States Hematology Testing Market, By Region:

North-East
Mid-West
West
South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States hematology testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on United States Hematology Testing Market

4. Executive Summary

5. Voice of Customer

6. United States Hematology Testing Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type (Hematology Instruments (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Others), Hematology Consumables (Reagents, Stains, Controls & Calibrators, Others)

6.2.2. By Type of Test (Complete Blood Count Analysis, White Blood Cell Analysis, Hemoglobin, Platelet Function, Reticulocytes, Others)

6.2.3. By Reagents (Coagulation reagents, Flow Cytometry reagents, Immuno-hematology reagents, Others)

6.2.4. By Application (Anemia, Hemoglobinopathy, leukemia/lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count)

6.2.5. By End User (Diagnostic Laboratories, Hospitals, Clinical Testing Laboratories, Academic Institutes, Patient Self-testing, Others)

6.2.6. By Region

6.2.7. By Company

6.3. Product Market Map

7. United States Hematology Instruments Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Hematology Instrument Type

7.2.2. By Type of Test

7.2.3. By Reagents

7.2.4. By Application

7.2.5. By End User

8. United States Hematology Consumables Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Hematology Consumables Type

8.2.2. By Type of Test

8.2.3. By Reagents

8.2.4. By Application

8.2.5. By End User

8.2.6. By Reagents

9. Market Dynamics

9.1. Drivers

9.2. Challenges

10. Market Trends & Development

11. Pricing Analysis

12. Policy & Regulatory Landscape

13. Import Export Analysis

14. United States Economic Profile

15. Competitive Landscape

15.1. Competition Outlook

15.2. Company Profiles

15.2.1. Abbott Laboratories, Inc.

15.2.2. Siemens Healthcare Diagnostics Inc.

15.2.3. Agilent Technologies Inc.

15.2.4. Bio-Rad Laboratories Inc.

15.2.5. Danaher Corporation

15.2.6. PerkinElmer Inc.

15.2.7. Thermo Fisher Scientific Inc.

15.2.8. Hoffmann-La Roche Inc.

15.2.9. Novo Nordisk, Inc.

15.2.10. Fluidigm Corporation

15.2.11. Microfluidics International Corporation

16. Strategic Recommendation

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

Who are the leading operating market players in the United States hematology testing market?

Abbott Laboratories, Inc., Siemens Healthcare Diagnostics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Inc., Novo Nordisk, Inc., Fluidigm Corporation, and Microfluidics International Corporation are the leading market players in the United States hematology testing market.

What type of test is expected to dominate United States hematology testing market in the forecast period?

Based on the type of test, the market is divided into complete blood count analysis, white blood cell analysis, hemoglobin, platelet function, reticulocytes, others. complete blood count analysis is expected to dominate the market share during the forecast period.

What end user is expected to dominate the United States hematology testing market in the forecast period?

Based on end user, the market can be segmented into diagnostic laboratories, hospitals, clinical testing laboratories, academic institutes, patient self-testing, others. Diagnostic laboratories are expected to hold the largest market during the forecast period.

What are the primary drivers of the United States hematology testing market in the forecast period?

The increasing prevalence of blood disorders and the growing healthcare expenditure drive the United States hematology testing market demand during the forecast period.